Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Knight

Showing results (641-650 of 666) with videos related to

Pageof 67
Sort By:
Lupus|July 25, 2020
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION RegistryStéphane Zuily, Isabelle Clerc-Urmès, Cédric Bauman, et al.
Rheumatology (Oxford, England)|October 18, 2024
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")Irene Cecchi, Massimo Radin, Silvia Grazietta Foddai, et al.
European Journal of Heart Failure|November 13, 2023
Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?Yousuf Razvi, Adam Ioannou, Rishi K Patel, et al.
Nature Communications|July 14, 2023
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVIDMatthew C Woodruff, Kevin S Bonham, Fabliha A Anam, et al.
Journal of the American College of Cardiology|February 18, 2026
Atrial Mechanical Contraction Predicts Cerebrovascular Risk in Patients With Transthyretin Amyloid Cardiomyopathy and Sinus RhythmAldostefano Porcari, Beatrice Dal Passo, Lucia Venneri, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2023
Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and RepositoryYu Zuo, Sherwin Navaz, Alex Tsodikov, et al.
Rheumatology (Oxford, England)|June 12, 2023
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registryGustavo G M Balbi, Yasaman Ahmadzadeh, Maria G Tektonidou, et al.
Nature Genetics|September 10, 2002
Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromesShinji Kondo, Brian C Schutte, Rebecca J Richardson, et al.
Cancer Immunology Research|September 4, 2025
Liver metastases license neutrophils through IL-1 to potentiate cancer progressionAshley N Pearson, Jessica Waninger, Amanda K Huber, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repositoryMaria Efthymiou, Ian J Mackie, Philip J Lane, et al.
Pageof 67

Showing results (641-650 of 666) with videos related to

Sort By:
Pageof 67
Lupus|July 25, 2020
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION RegistryStéphane Zuily, Isabelle Clerc-Urmès, Cédric Bauman, et al.
Rheumatology (Oxford, England)|October 18, 2024
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")Irene Cecchi, Massimo Radin, Silvia Grazietta Foddai, et al.
European Journal of Heart Failure|November 13, 2023
Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?Yousuf Razvi, Adam Ioannou, Rishi K Patel, et al.
Nature Communications|July 14, 2023
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVIDMatthew C Woodruff, Kevin S Bonham, Fabliha A Anam, et al.
Journal of the American College of Cardiology|February 18, 2026
Atrial Mechanical Contraction Predicts Cerebrovascular Risk in Patients With Transthyretin Amyloid Cardiomyopathy and Sinus RhythmAldostefano Porcari, Beatrice Dal Passo, Lucia Venneri, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2023
Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and RepositoryYu Zuo, Sherwin Navaz, Alex Tsodikov, et al.
Rheumatology (Oxford, England)|June 12, 2023
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registryGustavo G M Balbi, Yasaman Ahmadzadeh, Maria G Tektonidou, et al.
Nature Genetics|September 10, 2002
Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromesShinji Kondo, Brian C Schutte, Rebecca J Richardson, et al.
Cancer Immunology Research|September 4, 2025
Liver metastases license neutrophils through IL-1 to potentiate cancer progressionAshley N Pearson, Jessica Waninger, Amanda K Huber, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repositoryMaria Efthymiou, Ian J Mackie, Philip J Lane, et al.
Pageof 67